Zolpimist FDA Approval History
FDA Approved: Yes (First approved December 19, 2008)
Brand name: Zolpimist
Generic name: zolpidem tartrate
Dosage form: Oral Spray
Company: NovaDel Pharma, Inc.
Treatment for: Insomnia
Zolpimist is an oral spray formulation of zolpidem, the drug contained in Ambien. Zolpimist is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
Development Timeline for Zolpimist
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.